COMP <GO>
HII vs TMO // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Huntington Ingalls Industries Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: HII 8
— TMO 6
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: TMO
LAST: $316.88 (+0.21%) • MKT CAP: $12.46B
options-implied-move
7.00%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
options-implied-move
6.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HII VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HII | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.30% | 9.30% | -1.00 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.6x | 30.4x | -16.80 | HII | /valuation <GO> |
| Free Cash Flow Yield | 6.37% | 2.40% | +3.97 | HII | /fcf-yield <GO> |
| Operating Margin | 5.30% | 17.40% | -12.10 | TMO | /operating-margins <GO> |
| Net Profit Margin | 4.80% | 15.10% | -10.30 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 8.20% | 3.90% | +4.30 | HII | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.71% | 0.24% | +1.47 | HII | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.76 | 4.50 | -1.74 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | HII | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 7.00% | 6.70% | +0.30 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 75.9 | 59.1 | +16.79 | HII | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 0.94 | +0.08 | HII | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.2x | 36.3x | -17.10 | HII | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.46B | $262.22B | -$249.76B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HII REV | TMO REV | HII GROSS % | TMO GROSS % | HII FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $12.48B | $44.56B | 44.0% | 44.0% | $794.0M | $6.29B |
| FY 2024 | $11.54B | $42.88B | 44.0% | 44.0% | $26.0M | $7.27B |
| FY 2023 | $11.45B | $42.86B | 44.0% | 44.0% | $454.6M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HII // BETA 1.02
TMO // BETA 0.94